Multimodal predictors for Alzheimer disease in nonfluent primary progressive aphasia
Abstract
Objective: Alzheimer disease (AD) and frontotemporal lobar degeneration (FTLD) are hypothesized to cause clinically distinct forms of primary progressive aphasia (PPA) that predominantly affect expressive speech. AD is thought to cause logopenic progressive aphasia (LPA), and FTLD may cause progressive nonfluent aphasia (PNFA). We sought to determine the value of clinical characterization, neuropsychological analysis, and MRI atrophy in predicting pathology of LPA and PNFA.
Methods: Patients with LPA (n = 19) and patients with PNFA (n = 19) were evaluated with neuropsychological assessments, structural MRI, CSF analysis, and neuropathologic examination.
Results: Twelve of 19 patients with LPA (63%) and 6 of 19 patients with PNFA (32%) had neuropathologic findings or CSF biomarkers consistent with AD. Neuropsychological testing showed that naming was more impaired in patients with AD, and letter-guided fluency was more affected in patients with a non-AD disorder. Voxel-based morphometry analysis revealed that in patients with AD, patients with LPA and PNFA had significant posterior-superior temporal atrophy; in patients with non-AD, patients with LPA had peri-Sylvian atrophy and patients with PNFA had dorsolateral prefrontal and insular atrophy. Receiver operator characteristic curve analysis showed that combining neuropsychological testing with MRI atrophy pattern had 90% specificity for pathology or CSF biomarkers consistent with AD, and combining clinical features with neuropsychological analysis had 100% sensitivity for pathology or CSF biomarkers consistent with AD.
Conclusions: Neither PPA phenotyping nor imaging alone is a reliable predictor of pathology. Multimodal predictors, such as combining neuropsychological testing with MRI analysis, can improve noninvasive prediction of underlying pathology in nonfluent forms of PPA.
Get full access to this article
View all available purchase options and get full access to this article.
Supplementary Material
REFERENCES
1.
Mesulam MM. Slowly progressive aphasia without generalized dementia. Ann Neurol 1982;11:592–598.
2.
Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998;51:1546–1554.
3.
McKhann GM, Albert MS, Grossman M, Miller B, Dickson D, Trojanowski JQ. Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. Arch Neurol 2001;58:1803–1809.
4.
Gorno-Tempini ML, Dronkers NF, Rankin KP, et al. Cognition and anatomy in three variants of primary progressive aphasia. Ann Neurol 2004;55:335–346.
5.
Grossman M, McMillan C, Moore P, et al. What's in a name: voxel-based morphometric analyses of MRI and naming difficulty in Alzheimer's disease, frontotemporal dementia and corticobasal degeneration. Brain 2004;127:628–649.
6.
Knibb JA, Xuereb JH, Patterson K, Hodges JR. Clinical and pathological characterization of progressive aphasia. Ann Neurol 2006;59:156–165.
7.
Josephs KA, Duffy JR, Strand EA, et al. Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech. Brain 2006;129:1385–1398.
8.
Forman MS, Farmer J, Johnson JK, et al. Frontotemporal dementia: clinicopathological correlations. Ann Neurol 2006;59:952–962.
9.
Galton CJ, Patterson K, Xuereb JH, Hodges JR. Atypical and typical presentations of Alzheimer's disease: a clinical, neuropsychological, neuroimaging and pathological study of 13 cases. Brain 2000;123:484–498.
10.
Gorno-Tempini ML, Brambati SM, Ginex V, et al. The logopenic/phonological variant of primary progressive aphasia. Neurology 2008;71:1227–1234.
11.
Mesulam M, Wicklund A, Johnson N, et al. Alzheimer and frontotemporal pathology in subsets of primary progressive aphasia. Ann Neurol 2008;63:709–719.
12.
Greene JD, Patterson K, Xuereb J, Hodges JR. Alzheimer disease and nonfluent progressive aphasia. Arch Neurol 1996;53:1072–1078.
13.
Grossman M, Xie SX, Libon DJ, et al. Longitudinal decline in autopsy-defined frontotemporal lobar degeneration. Neurology 2008;70:2036–2045.
14.
Bian H, Van Swieten JC, Leight S, et al. CSF biomarkers in frontotemporal lobar degeneration with known pathology. Neurology 2008;70:1827–1835.
15.
Hyman BT, Trojanowski JQ. Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease. J Neuropathol Exp Neurol 1997;56:1095–1097.
16.
Cairns NJ, Bigio EH, Mackenzie IR, et al. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol 2007;114:5–22.
17.
Dickson DW, Bergeron C, Chin SS, et al. Office of Rare Diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol 2002;61:935–946.
18.
Hauw JJ, Daniel SE, Dickson D, et al. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 1994;44:2015–2019.
19.
Greenberg SG, Davies P. A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis. Proc Natl Acad Sci USA 1990;87:5827–5831.
20.
Giasson BI, Duda JE, Murray IV, et al. Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science 2000;290:985–989.
21.
Maldjian JA, Laurienti PJ, Kraft RA, Burdette JH. An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage 2003;19:1233–1239.
22.
Josephs KA, Petersen RC, Knopman DS, et al. Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP. Neurology 2006;66:41–48.
23.
Weintraub S, Rubin NP, Mesulam MM. Primary progressive aphasia: longitudinal course, neuropsychological profile, and language features. Arch Neurol 1990;47:1329–1335.
24.
Josephs KA, Whitwell JL, Duffy JR, et al. Progressive aphasia secondary to Alzheimer disease vs FTLD pathology. Neurology 2008;70:25–34.
25.
Rabinovici GD, Seeley WW, Kim EJ, et al. Distinct MRI atrophy patterns in autopsy-proven Alzheimer's disease and frontotemporal lobar degeneration. Am J Alzheimers Dis Other Demen 2007;22:474–488.
26.
Shaw LM, Vanderstichele H, Knapik-Czajka M, et al. Cerebrospinal fluid biomarkers signature in Alzheimer's Disease Neuroimaging Initiative subjects. Ann Neurol Epub 2009.
27.
Leinonen V, Alafuzoff I, Aalto S, et al. Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled Pittsburgh Compound B. Arch Neurol 2008;65:1304–1309.
28.
Borroni B, Brambati SM, Agosti C, et al. Evidence of white matter changes on diffusion tensor imaging in frontotemporal dementia. Arch Neurol 2007;64:246–251.
29.
Ray S, Britschgi M, Herbert C, et al. Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nat Med 2007;13:1359–1362.
30.
Kovacevic S, Rafii MS, Brewer JB. High-throughput, fully automated volumetry for prediction of MMSE and CDR decline in mild cognitive impairment. Alzheimer Dis Assoc Disord 2009;23:139–145.
Information & Authors
Information
Published In
Copyright
© 2010.
Publication History
Published online: August 16, 2010
Published in print: August 17, 2010
Keyword
Authors
Metrics & Citations
Metrics
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
Cited By
- Artificial intelligence-based early detection of neurological disease using noninvasive method based on speech analysis, Artificial Intelligence for Neurological Disorders, (305-321), (2023).https://doi.org/10.1016/B978-0-323-90277-9.00008-0
- Network anatomy in logopenic variant of primary progressive aphasia, Human Brain Mapping, 44, 11, (4390-4406), (2023).https://doi.org/10.1002/hbm.26388
- Alzheimer’s disease diagnosis using genetic programming based on higher order spectra features, Machine Learning with Applications, 7, (100225), (2022).https://doi.org/10.1016/j.mlwa.2021.100225
- Characterization of the logopenic variant of Primary Progressive Aphasia: A systematic review and meta-analysis, Ageing Research Reviews, 82, (101760), (2022).https://doi.org/10.1016/j.arr.2022.101760
- Neurodegenerative Disorders of Speech and Language: Non-language-dominant Diseases, Encyclopedia of Behavioral Neuroscience, 2nd edition, (66-80), (2022).https://doi.org/10.1016/B978-0-12-819641-0.00042-6
- Primary Progressive Aphasia Associated With GRN Mutations, Neurology, 97, 1, (e88-e102), (2021)./doi/10.1212/WNL.0000000000012174
- Research advances in neuroimaging and genetic characteristics of the non-fluent/agrammatic variant of primary progressive aphasia, Chinese Medical Journal, 134, 6, (665-667), (2021).https://doi.org/10.1097/CM9.0000000000001424
- Multi-Objective Optimization of Wavelet-Packet-Based Features in Pathological Diagnosis of Alzheimer Using Spontaneous Speech Signals, IEEE Access, 8, (112393-112406), (2020).https://doi.org/10.1109/ACCESS.2020.3001426
- Les aphasies primaires progressives, Pratique Neurologique - FMC, 10, 2, (96-100), (2019).https://doi.org/10.1016/j.praneu.2019.02.002
- 18F-flortaucipir uptake patterns in clinical subtypes of primary progressive aphasia, Neurobiology of Aging, 75, (187-197), (2019).https://doi.org/10.1016/j.neurobiolaging.2018.11.017
- See more
Loading...
View Options
Get Access
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
Purchase this article to access the full text.